MYCN and neuroblastoma: This likely explains the physiologic expression of MYCN observed in nontransformed adrenergic neuroblasts that serve as the cell of origin for this form of neuroblastoma, and is supported by the theory that genomic amplification events require active gene expression to be selected for in tumorigenesis (47).